https://www.selleckchem.com/products/jke-1674.html
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has infected 235 million people and killed over 4.8 million individuals worldwide. Although vaccines have been developed for prophylactic management, there are no clinically proven antivirals to treat the viral infection. Continuous efforts are being made all over the world to develop effective drugs but these are being delayed by periodic outbreak of mutated SARS-CoV-2 and a lack of knowledge of molecular mechanisms underlying viral pathogenesis and post-infection compli
Like
Comment
Share
